Astra, BMS Diabetes Drug Succeeds in Latest Trial

An experimental diabetes drug from AstraZeneca and Bristol-Myers Squibb met its target in a late-stage trial as a combination therapy, working as well as a comparison in reducing blood sugar levels.
Futures Pros